Viemed Healthcare Inc
TSX:VMD

Watchlist Manager
Viemed Healthcare Inc Logo
Viemed Healthcare Inc
TSX:VMD
Watchlist
Price: 10.45 CAD 2.85% Market Closed
Market Cap: 402.2m CAD

Viemed Healthcare Inc
Investor Relations

Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. The company is headquartered in Lafayette, Louisiana. The company went IPO on 2017-12-22. Viemed is focused on providing in-home treatment with clinical practitioners and providing therapy, and counseling to patients in their homes using technology. Viemed’s products and services include Home Medical Equipment and In-home sleep testing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. The company provides home medical equipment through a range of service programs, including respiratory disease management, Neuromuscular care, Oxygen therapy and Sleep apnea. In-home sleep testing provides in home sleep apnea testing services, which is an alternative to the traditional sleep lab testing environment.

Show more
Loading
VMD
S&P TSX Composite Index (Canada)

Earnings Calls

2023 Q3
Nov 2, 2023
Show Transcript
Previous
Next
Robust Growth and Strong Margins Drive Viemed's Q3 Performance
2023 Q3
Nov 2, 2023

Viemed's financial success continued in the third quarter of 2023, marked by a net revenue of $49.4 million, a 38% increase over the same quarter last year. Organic growth was striking, with a 19% rise over the previous year's quarter, despite revenue from vents decreasing from 67% to 58% of core revenue. The gross margin reached the highest in two years at 61.9%, and EBITDA margin improved to 24.5%, resulting in a 73% increase in EBITDA over last year. Management efficiently controlled costs, resulting in an expansion of EBITDA margin. CapEx investment was at $7.4 million, primarily in vents and oxygen equipment, supported by a robust cash flow. The company's balance sheet remains robust, ending the quarter with $10 million in cash and working capital of $4 million while reducing long-term debt to $8 million. Looking forward, net revenue is expected to be between $49.8 million and $51 million in Q4 2023.

Management

Mr. Casey Hoyt
CEO & Director
No Bio Available
Mr. Michael B. Moore CRT
Pres
No Bio Available
Mr. Trae Paul Fitzgerald
Chief Financial Officer
No Bio Available
Mr. William Todd Zehnder
COO & Director
No Bio Available
Dr. William Dana Frazier M.D.
Chief Medical Officer & Director
No Bio Available
Mr. Jeremy Trahan
Chief Legal Officer and Exec. VP of Acquisitions & Strategic Transactions
No Bio Available
Mr. Patrick Eagan
Gen. Counsel
No Bio Available
Mr. Michael Freeman
Chief Bus. Devel. Officer
No Bio Available
Mr. Robert Grossman LLB
Corp. Sec.
No Bio Available

Contacts

Address
LOUISIANA
Lafayette
625 E. Kaliste Saloom Rd.
Contacts
+13375043802.0
www.viemed.com